Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent

被引:217
作者
Compton, P
Charuvastra, VC
Ling, W
机构
[1] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Integrated Subst Abuse Programs, Los Angeles, CA 90095 USA
关键词
pain; methadone; buprenorphine; cold presser; hyperalgesia;
D O I
10.1016/S0376-8716(00)00200-3
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Patients on methadone maintenance therapy are relatively intolerant of pain, a finding hypothesized to reflect a hyperalgesic state induced by chronic opioid administration. To explore if the intrinsic activity of the opioid maintenance agent might affect expression of hyperalgesia in this population, withdrawal latency for cold-presser (CP) pain was compared between small groups of methadone-maintained (n = 18), buprenorphine-maintained (n = 18), and matched control (n = 18) subjects. The opioid-maintained groups had equal and significantly shorter withdrawal latencies than controls, however it is possible that highs rates of continued illicit opioid use precluded finding differences between methadone and buprenorphine groups. Differential effects of maintenance agent were found for the few subjects without illicit opioid use, such that withdrawal latencies for methadone-maintained (n = 5) were less than for buprenorphine-maintained (n = 7) which were less than controls tit = 18). Diminished pain tolerance in patients receiving opioid maintenance treatment has significant clinical implications. More research is needed to determine if buprenorphine offers advantages over methadone in this regard. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 84 条
[51]   EXPERIMENTAL MONONEUROPATHY REDUCES THE ANTINOCICEPTIVE EFFECTS OF MORPHINE - IMPLICATIONS FOR COMMON INTRACELLULAR MECHANISMS INVOLVED IN MORPHINE-TOLERANCE AND NEUROPATHIC PAIN [J].
MAO, JR ;
PRICE, DD ;
MAYER, DJ .
PAIN, 1995, 61 (03) :353-364
[52]  
Martin J E, 1965, Br J Soc Clin Psychol, V4, P224
[53]  
MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517
[54]  
Mayer D J, 1995, NIDA Res Monogr, V147, P269
[55]   THE DEVELOPMENT OF MORPHINE-TOLERANCE AND DEPENDENCE IS ASSOCIATED WITH TRANSLOCATION OF PROTEIN-KINASE-C [J].
MAYER, DJ ;
MAO, JR ;
PRICE, DD .
PAIN, 1995, 61 (03) :365-374
[56]   The genetics of pain and pain inhibition [J].
Mogil, JS ;
Sternberg, WF ;
Marek, P ;
Sadowski, B ;
Belknap, JK ;
Liebeskind, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (07) :3048-3055
[57]   ONE OR 2 GENETIC-LOCI MEDIATE HIGH OPIATE ANALGESIA IN SELECTIVELY BRED MICE [J].
MOGIL, JS ;
MAREK, P ;
FLODMAN, P ;
SPENCE, MA ;
STERNBERG, WF ;
KEST, B ;
SADOWSKI, B ;
LIEBESKIND, JC .
PAIN, 1995, 60 (02) :125-135
[58]   The μ opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the μ opioid receptor [J].
Morgan, D ;
Picker, MJ .
PSYCHOPHARMACOLOGY, 1998, 140 (01) :20-28
[59]   An examination of the interactions between the antinociceptive effects of morphine and various μ-opioids:: The role of intrinsic efficacy and stimulus intensity [J].
Morgan, D ;
Cook, CD ;
Smith, MA ;
Picker, MJ .
ANESTHESIA AND ANALGESIA, 1999, 88 (02) :407-413
[60]  
Morgan D, 1999, J PHARMACOL EXP THER, V289, P965